Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

By Hatschek T.   Carlsson L.   Einbeigi Z.   Lidbrink E.   Linderholm B.   Lindh B.   Loman N.   Malmberg M.   Rotstein S.   Söderberg M.   Sundquist M.   Walz T.   Hellström M.   Svensson H.   Åström G.   Brandberg Y.   Carstensen J.   Fernö M.   Bergh J.  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 939-947

Springer Publishing Company

Access to resources Recommend Favorite

Sequential versus simultaneous use of vinorelbine and capecitabine at the same dosage as first-line chemotherapy for patients with metastatic breast cancer

By Gu Shiyang   Zhang Ping   Jia Zhen   Wang Biyun   Zhang Jian   Wang Zhonghua   Guo Haiyi   Wang Jialei   Zhao Xinmin   Hu Xichun  

The Chinese-German Journal of Clinical Oncology, Vol. 9, Iss. 9, 2010-09 ,pp. : 528-535

Springer Publishing Company

Access to resources Recommend Favorite

Vinorelbine as first-line or second-line therapy for advanced breast cancer: A Phase I-II trial by the Danish Breast Cancer Co-operative Group

By Langkjer Sven   Ejlertsen Bent   Mouridsen Henning   Andersen Jørn   Møller Nielsen Mette   Åge Møller Knud   Lindegaard Madsen Ebbe   Haarh Vera  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 735-739

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel and Epirubicin as First-Line Treatment for Patients with Metastatic Breast Cancer: A Minnie Pearl Cancer Research Network Phase II Trial

By Hainsworth John   Yardley Denise   Spigel David   Meluch Anthony   Rinaldi David   Schnell Frederick   Greco F.  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 469-473

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine and Epirubicin in Metastatic Breast Cancer. A Dose Finding Study

By Blomqvist C.   Hietanen P.   Teerenhovi L.   Rissanen P.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2406-2408

Elsevier

Access to resources Recommend Favorite